Extracorporeal photopheresis-induced immune tolerance: A focus on modulation of antigen-presenting cells and induction of regulatory T cells by apoptotic cells

Current Opinion in Organ Transplantation

Volumn 14, Issue 4, 2009, Pages 338-343

  Xia, Chang Qing ^a   Campbell, Kim A ^b   Clare Salzler, Michael J ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b Therakos   (United States)

Author keywords

Apoptosis; Extracorporeal photopheresis; Immune tolerance; Regulatory T cell

Indexed keywords

PSORALEN;

ANTIGEN PRESENTING CELL; APOPTOSIS; B LYMPHOCYTE; CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL ACTIVATION; CELLULAR IMMUNITY; DENDRITIC CELL; EXTRACORPOREAL CIRCULATION; EXTRACORPOREAL PHOTOPHERESIS; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; LYMPHOCYTE PROLIFERATION; MACROPHAGE; NONHUMAN; PUVA; REGULATORY T LYMPHOCYTE; REVIEW;

ANIMALS; ANTIGEN-PRESENTING CELLS; APOPTOSIS; CELL DIFFERENTIATION; HUMANS; IMMUNOSUPPRESSION; INTERLEUKIN-10; ORGAN TRANSPLANTATION; PHOTOPHERESIS; RECEPTOR PROTEIN-TYROSINE KINASES; SIGNAL TRANSDUCTION; T-LYMPHOCYTES, REGULATORY; TRANSPLANTATION TOLERANCE;

EID: 68849088692     PISSN: 10872418     EISSN: 15317013     Source Type: Journal    
DOI: 10.1097/MOT.0b013e32832ce943     Document Type: Review

References (63)

1. Edelson R, Berger C, Gasparro F, et al. Treatment of cutaneous T-cell lymphoma by extracorporeal photochemotherapy. Preliminary results. N Engl J Med 1987; 316:297-303. (Pubitemid 17036377)
2. McKenna KE, Whittaker S, Rhodes LE, et al. Evidence-based practice of photopheresis 1987-2001: a report of a workshop of the British Photodermatology Group and the U.K. Skin Lymphoma Group. Br J Dermatol 2006; 154:7-20.
3. Marshall SR. Technology insight: ECP for the treatment of GvHD: can we offer selective immune control without generalized immunosuppression? Nat Clin Pract Oncol 2006; 3:302-314.
4. Flowers ME, Apperley JF, van Besien K, et al. A multicenter prospective phase 2 randomized study of extracorporeal photopheresis for treatment of chronic graft-versus-host disease. Blood 2008; 112:2667-2674.
5. Greinix HT, Socie G, Bacigalupo A, et al. Assessing the potential role of photopheresis in hematopoietic stem cell transplant. Bone Marrow Transplant 2006; 38:265-273. (Pubitemid 44203776)
6. Steinman RM, Turley S, Mellman I, Inaba K. The induction of tolerance by dendritic cells that have captured apoptotic cells. J Exp Med 2000; 191:411-416. (Pubitemid 30693565)
7. Morelli AE, Larregina AT, Shufesky WJ, et al. Internalization of circulating apoptotic cells by splenic marginal zone dendritic cells: dependence on complement receptors and effect on cytokine production. Blood 2003; 101:611-620.
8. Di Renzo M, Sbano P, De Aloe G, et al. Extracorporeal photopheresis affects co-stimulatory molecule expression and interleukin-10 production by dendritic cells in graft-versus-host disease patients. Clin Exp Immunol 2008; 151:407-413. (Pubitemid 351160727)
9. Holtick U, Marshall SR, Wang XN, et al. Impact of psoralen/UVA-treatment on survival, activation, and immunostimulatory capacity of monocyte-derived dendritic cells. Transplantation 2008; 85:757-766.
10. Lamioni A, Parisi F, Isacchi G, et al. The immunological effects of extracorporeal photopheresis unraveled: induction of tolerogenic dendritic cells in vitro and regulatory T cells in vivo. Transplantation 2005; 79:846-850. (Pubitemid 40546206)
11. Legitimo A, Consolini R, Failli A, et al. In vitro treatment of monocytes with 8-methoxypsolaren and ultraviolet A light induces dendritic cells with a tolerogenic phenotype. Clin Exp Immunol 2007; 148:564-572.
12. Birge RB, Ucker DS. Innate apoptotic immunity: the calming touch of death. Cell Death Differ 2008; 15:1096-1102.
13. Sauter B, Albert ML, Francisco L, et al. Consequences of cell death: exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells. J Exp Med 2000; 191:423-434. (Pubitemid 30693567)
14. Fry TJ, Shand JL, Milliron M, et al. Antigen loading of DCs with irradiated apoptotic tumor cells induces improved antitumor immunity compared to other approaches. Cancer Immunol Immunother 2009. [Epub ahead of print]
15. Albert ML. Death-defying immunity: do apoptotic cells influence antigen processing and presentation? Nat Rev Immunol 2004; 4:223-231.
16. Clayton AR, Prue RL, Harper L, et al. Dendritic cell uptake of human apoptotic and necrotic neutrophils inhibits CD40, CD80, and CD86 expression and reduces allogeneic T cell responses: relevance to systemic vasculitis. Arthritis Rheum 2003; 48:2362-2374.
17. Fadok VA, Bratton DL, Henson PM. Phagocyte receptors for apoptotic cells: recognition, uptake, and consequences. J Clin Invest 2001; 108:957-962.
18. Sakaguchi S, Yamaguchi T, Nomura T, Ono M. Regulatory T cells and immune tolerance. Cell 2008; 133:775-787.
19. Kim S, Elkon KB, Ma X. Transcriptional suppression of interleukin-12 gene expression following phagocytosis of apoptotic cells. Immunity 2004; 21:643-653. (Pubitemid 39487888)
20. Lemke G, Rothlin CV. Immunobiology of the TAM receptors. Nat Rev Immunol 2008; 8:327-336.
21. Lai C, Lemke G. An extended family of protein-tyrosine kinase genes differentially expressed in the vertebrate nervous system. Neuron 1991; 6:691-704.
22. O'Bryan JP, Frye RA, Cogswell PC, et al. axl, a transforming gene isolated from primary human myeloid leukemia cells, encodes a novel receptor tyrosine kinase. Mol Cell Biol 1991; 11:5016-5031.
23. Sen P, Wallet MA, Yi Z, et al. Apoptotic cells induce Mer tyrosine kinasedependent blockade of NF-kappaB activation in dendritic cells. Blood 2007; 109:653-660. (Pubitemid 46105966)
24. Rothlin CV, Ghosh S, Zuniga EI, et al. TAM receptors are pleiotropic inhibitors of the innate immune response. Cell 2007; 131:1124-1136. (Pubitemid 350235020)
25. Gaipl US, Munoz LE, Grossmayer G, et al. Clearance deficiency and systemic lupus erythematosus (SLE). J Autoimmun 2007; 28:114-121. (Pubitemid 46680499)
26. Janko C, Schorn C, Grossmayer GE, et al. Inflammatory clearance of apoptotic remnants in systemic lupus erythematosus (SLE). Autoimmun Rev 2008; 8:9-12.
27. Schulze C, Munoz LE, Franz S, et al. Clearance deficiency: a potential link between infections and autoimmunity. Autoimmun Rev 2008; 8:5-8.
28. Lauber K, Bohn E, Krober SM, et al. Apoptotic cells induce migration of phagocytes via caspase-3-mediated release of a lipid attraction signal. Cell 2003; 113:717-730. (Pubitemid 36724936)
29. Kobayashi N, Karisola P, Pena-Cruz V, et al. TIM-1 and TIM-4 glycoproteins bind phosphatidylserine and mediate uptake of apoptotic cells. Immunity 2007; 27:927-940. (Pubitemid 50014866)
30. Miyanishi M, Tada K, Koike M, et al. Identification of Tim4 as a phosphatidylserine receptor. Nature 2007; 450:435-439.
31. Kazama H, Ricci JE, Herndon JM, et al. Induction of immunological tolerance by apoptotic cells requires caspase-dependent oxidation of high-mobility group box-1 protein. Immunity 2008; 29:21-32. Demonstrates that the activation of caspases on mitochondria when cells are undergoing apoptosis promotes production of reactive oxygen species (ROS), which can oxidize potent proinflammatory HMGB1 released from apoptotic cells and HMGB1 loses its proinflammatory activity. This process is another newly discovered mechanism that enables apoptotic cell function against inflammation and facilitates tolerance induction.
32. Raucci A, Palumbo R, Bianchi ME. HMGB1: a signal of necrosis. Autoimmunity 2007; 40:285-289.
33. Rovere-Querini P, Capobianco A, Scaffidi P, et al. HMGB1 is an endogenous immune adjuvant released by necrotic cells. EMBO Rep 2004; 5:825-830. (Pubitemid 39199174)
34. Zong WX, Ditsworth D, Bauer DE, et al. Alkylating DNA damage stimulates a regulated form of necrotic cell death. Genes Dev 2004; 18:1272-1282. (Pubitemid 38720595)
35. Choi JJ, Reich CF 3rd, Pisetsky DS. Release of DNA from dead and dying lymphocyte and monocyte cell lines in vitro. Scand J Immunol 2004; 60:159-166.
36. Bell CW, Jiang W, Reich CF 3rd, Pisetsky DS. The extracellular release of HMGB1 during apoptotic cell death. Am J Physiol Cell Physiol 2006; 291:C1318-1325.
37. Jeannin P, Jaillon S, Delneste Y. Pattern recognition receptors in the immune response against dying cells. Curr Opin Immunol 2008; 20:530-537.
38. Liu G, Wang J, Park YJ, et al. High mobility group protein-1 inhibits phagocytosis of apoptotic neutrophils through binding to phosphatidylserine. J Immunol 2008; 181:4240-4246. Illustrates that apoptotic neutrophils release HMGB1, which blocks the recognition and phagocytosis of apoptotic cells by phagocytes through binding to phosphatidylserine on apoptotic cells.
39. Urbonaviciute V, Furnrohr BG, Meister S, et al. Induction of inflammatory and immune responses by HMGB1-nucleosome complexes: implications for the pathogenesis of SLE. J Exp Med 2008; 205:3007-3018. Shows that due to impairment of apoptotic cell clearance in SLE individuals, the apoptotic cells release HMGB1-nucleosome complexes, which activate macrophages and dendritic cells through binding to TLR2 to undergo a maturation process and produce proinflammatory cytokines.
40. Spisek R, Gasova Z, Bartunkova J. Maturation state of dendritic cells during the extracorporeal photopheresis and its relevance for the treatment of chronic graft-versus-host disease. Transfusion 2006; 46:55-65. (Pubitemid 43381785)
41. Gray M, Miles K, Salter D, et al. Apoptotic cells protect mice from autoimmune inflammation by the induction of regulatory B cells. Proc Natl Acad Sci U S A 2007; 104:14080-14085. (Pubitemid 350003338)
42. Cobbold SP. Regulatory T cells and transplantation tolerance. J Nephrol 2008; 21:485-496.
43. Dijke IE, Weimar W, Baan CC. Regulatory T cells after organ transplantation: where does their action take place? Hum Immunol 2008; 69:389-398.
44. Kleinclauss F, Perruche S, Masson E, et al. Intravenous apoptotic spleen cell infusion induces a TGF-beta-dependent regulatory T-cell expansion. Cell Death Differ 2006; 13:41-52.
45. Belghith M, Bluestone JA, Barriot S, et al. TGF-beta-dependent mechanisms mediate restoration of self-tolerance induced by antibodies to CD3 in overt autoimmune diabetes. Nat Med 2003; 9:1202-1208. (Pubitemid 37173706)
46. Bluestone JA, Tang Q. Therapeutic vaccination using CD4+CD25+ antigen-specific regulatory T cells. Proc Natl Acad Sci U S A 2004; 101 (Suppl 2): 14622-14626.
47. Perruche S, Zhang P, Liu Y, et al. CD3-specific antibody-induced immune tolerance involves transforming growth factor-beta from phagocytes digesting apoptotic T cells. Nat Med 2008; 14:528-535. Uncovers the mechanism of CD3-specific antibody treatment-induced immune tolerance that involves TGF-b production by phagocytes in the process of digesting apoptotic T cells, induced by CD3 antibody therapy. (Pubitemid 351655213)
48. Maeda A, Schwarz A, Kernebeck K, et al. Intravenous infusion of syngeneic apoptotic cells by photopheresis induces antigen-specific regulatory T cells. J Immunol 2005; 174:5968-5976. (Pubitemid 40663783)
49. Gatza E, Rogers CE, Clouthier SG, et al. Extracorporeal photopheresis reverses experimental graft-versus-host disease through regulatory T cells. Blood 2008; 112:1515-1521. Provides experimental evidence that ECP therapy not only prevents but also reverses GvHD in a murine model of bone marrow transplantation via induction of adaptive regulatory T cells.
50. Biagi E, x Di Biaso I, Leoni V, et al. Extracorporeal photochemotherapy is accompanied by increasing levels of circulating CD4+CD25+GITR+ FoxP3+CD62L+ functional regulatory T-cells in patients with graft-versus-host disease. Transplantation 2007; 84:31-39.
51. Meloni F, Cascina A, Miserere S, et al. Peripheral CD4+CD25+ Treg cell counts and the response to extracorporeal photopheresis in lung transplant recipients. Transplant Proc 2007; 39:213-217. (Pubitemid 46175985)
52. Lamioni A, Carsetti R, Legato A, et al. Induction of regulatory T cells after prophylactic treatment with photopheresis in renal transplant recipients. Transplantation 2007; 83:1393-1396. (Pubitemid 46800319)
53. Battaglia M, Gianfrani C, Gregori S, Roncarolo MG. IL-10-producing T regulatory type 1 cells and oral tolerance. Ann N Y Acad Sci 2004; 1029:142-153. (Pubitemid 40298525)
54. Xia CQ, Peng R, Qiu Y, et al. Transfusion of apoptotic beta-cells induces immune tolerance to beta-cell antigens and prevents type 1 diabetes in NOD mice. Diabetes 2007; 56:2116-2123. (Pubitemid 47195837)
55. Xia CQ, Qiu Y, Peng RH, et al. Infusion of UVB-treated splenic stromal cells induces suppression of beta cell antigen-specific T cell responses in NOD mice. J Autoimmun 2008; 30:283-292.
56. Maeda A, Beissert S, Schwarz T, Schwarz A. Phenotypic and functional characterization of ultraviolet radiation-induced regulatory T cells. J Immunol 2008; 180:3065-3071.
57. + Tregs in the induction phase of contact hypersensitivity produce high levels of IL-10, which plays a critical role for induction of IL-10-producing regulatory T cells, which are major players in effector phases of contact hypersensitivity.
58. Griffith TS, Kazama H, Van Oosten RL, et al. Apoptotic cells induce tolerance by generating helpless CD8+ T cells that produce TRAIL. J Immunol 2007; 178:2679-2687. (Pubitemid 46333144)
59. Baadsgaard O, Salvo B, Mannie A, et al. In vivo ultraviolet-exposed human epidermal cells activate T suppressor cell pathways that involve CD4+CD45RA+ suppressor-inducer T cells. J Immunol 1990; 145: 2854-2861.
60. Ishimaru H, Matsuda T. T cell subsets (Tc, Th, Ts, Tsi) and IL2 receptorbearing cells in peripheral blood of patients in the acute phase of alcoholic hepatitis. Alcohol Alcoholism 1990; 25:353-358. (Pubitemid 20285199)
61. Satoh T, Tokura Y, Satoh Y, Takigawa M. Ultraviolet-induced suppressor T cells and factor(s) in murine contact photosensitivity. III. Mode of action of Tcell-suppressor factor(s) and interaction with cytokines. Cell Immunol 1990; 131:120-131.
62. Herzenberg LA, Okumura K, Cantor H, et al. T-cell regulation of antibody responses: demonstration of allotype-specific helper T cells and their specific removal by suppressor T cells. J Exp Med 1976; 144:330-344.
63. Okumura K, Herzenberg LA, Murphy DB, et al. Selective expression of H-2 (I-region) loci controlling determinants on helper and suppressor T lymphocytes. J Exp Med 1976; 144:685-698.